Tenocin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-01-2025
- Paid Up Capital ₹ 0.10 M
as on 06-01-2025
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 06-01-2025
- Revenue 704.47%
(FY 2020)
- Profit 640.44%
(FY 2020)
- Ebitda 416.78%
(FY 2020)
- Net Worth 8.04%
(FY 2020)
- Total Assets 45.69%
(FY 2020)
About Tenocin Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Gita Chauhan and Sujan Singh serve as directors at the Company.
- CIN/LLPIN
U85200UP2018PTC105127
- Company No.
105127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tenocin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gita Chauhan  | Director | 08-Jun-2018 | Current |
| Sujan Singh | Director | 08-Jun-2018 | Current |
Financial Performance of Tenocin Pharmaceuticals.
Tenocin Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 704.47% increase. The company also saw a substantial improvement in profitability, with a 640.44% increase in profit. The company's net worth moved up by a moderate rise of 8.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenocin Pharmaceuticals?
In 2020, Tenocin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 05 Oct 2019 | ₹0.50 M | Open |
How Many Employees Work at Tenocin Pharmaceuticals?
Unlock and access historical data on people associated with Tenocin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenocin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenocin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
